panaxydol has been researched along with aristolochic acid i in 1 studies
*aristolochic acid I: phospholipase A inhibitor [MeSH]
*aristolochic acid I: phospholipase A inhibitor [MeSH]
| Studies (panaxydol) | Trials (panaxydol) | Recent Studies (post-2010) (panaxydol) | Studies (aristolochic acid i) | Trials (aristolochic acid i) | Recent Studies (post-2010) (aristolochic acid i) |
|---|---|---|---|---|---|
| 30 | 1 | 14 | 1,088 | 2 | 548 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alharbi, SA; Chinnathambi, A; Ge, P; Guo, Y; Hu, M; Ma, J; Shair, OHM | 1 |
1 other study(ies) available for panaxydol and aristolochic acid i
| Article | Year |
|---|---|
Protective effect of panaxydol against repeated administration of aristolochic acid on renal function and lipid peroxidation products via activating Keap1-Nrf2/ARE pathway in rat kidney.
Topics: Acute Kidney Injury; Animals; Aristolochic Acids; Diynes; Fatty Alcohols; Kelch-Like ECH-Associated Protein 1; Kidney; Lipid Peroxidation; Male; NF-E2-Related Factor 2; Rats; Rats, Wistar; Signal Transduction | 2021 |